PenderFund Capital Management Ltd. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PenderFund Capital Management Ltd. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$29,833
+42.9%
41,029,000
+30.9%
8.94%
+37.8%
Q2 2023$20,870
+112.4%
31,354,000
+79.6%
6.49%
+110.2%
Q1 2023$9,826
-38.1%
17,454,000
-17.3%
3.09%
-34.8%
Q4 2022$15,872
-99.9%
21,104,000
-28.9%
4.73%
-36.2%
Q3 2022$23,720,000
+11.0%
29,679,0000.0%7.42%
+25.6%
Q2 2022$21,367,000
+8.4%
29,679,0000.0%5.91%
+22.4%
Q1 2022$19,704,00029,679,0004.83%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders